NCT06426758View on ClinicalTrials.gov

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions
Graves DiseaseGraves' Disease in RemissionEpstein-Barr Virus
Trial Locations (1)

210006

Nanjing First Hospital, Nanjing Medical University, Nanjing

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

lead

Xiao-Ming Mao

OTHER

NCT06426758 - Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation | Biotech Hunter | Biotech Hunter